Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07017972 · ClinicalTrials.gov registry record

Data Collection and Professional Simulated Use Study to Develop an Embryo Quality Artificial Intelligence (AI) Model

A clinical trial of Fertility Disorders, sponsored by Fairtility.

Recruiting
Registry status
4,000
Enrollment target
1
Study location

NCT07017972: Recruiting study of Fertility Disorders, sponsored by Fairtility.

NCT07017972 is a study of Fertility Disorders that is actively recruiting participants, run by Fairtility. The registered enrollment target is 4,000 participants, above the 261-participant average among 3 other Fertility Disorders trials with a reported enrollment target (1433% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07017972, a study of Fertility Disorders, is actively recruiting participants, sponsored by Fairtility.

RECRUITING
Registry status
4,000 participants
Enrollment target
1
Study location

Study Summary

This protocol supports the reliable development and improvement of Artificial Intelligence (AI)-based applications by enabling training, verification, and validation using high-quality real clinical data. It also aims to enhance machine learning in developmental-use AI software. In addition, the professional user simulated use will ensure correct and easy use of the AI applications.

Conditions Studied

Interventions

  • DEVICE AI evaluation of embryos

Study Locations (1)

Connecticut

  • New England Fertility Institute - Stamford

Trial Details

FieldValue
Enrollment Target 4,000 participants
Start Date 2025-06-20
Est. Completion 2027-06-20
Fairtility

4 total trials

What NCT07017972 shows while recruiting

NCT07017972 is an observational study that tracks outcomes without assigning an intervention. Its 4,000 participants enrollment target places it among the larger protocols in the corpus, above the 261-participant average among 3 other Fertility Disorders trials with a reported enrollment target (1433% higher).

The record links to 1 condition, with Fertility Disorders appearing as the primary indexed condition, and to 1 intervention - of which AI evaluation of embryos is the first listed.

NCT07017972 reports a single indexed study location in Connecticut.

Frequently Asked Questions

What is clinical trial NCT07017972 about?

NCT07017972 is a clinical study titled "Data Collection and Professional Simulated Use Study to Develop an Embryo Quality Artificial Intelligence (AI) Model". This protocol supports the reliable development and improvement of Artificial Intelligence (AI)-based applications by enabling training, verification, and validation using high-quality real clinical data. It also aims to enhance machine learning in developmental-use AI software. In addition, the pr...

What is the current status of trial NCT07017972?

This trial is currently recruiting. The enrollment target is 4,000 participants. The study started on 2025-06-20. Estimated completion is 2027-06-20.

What conditions does trial NCT07017972 study?

This clinical trial studies the following conditions: Fertility Disorders.

What interventions are being tested in trial NCT07017972?

The interventions under investigation include: AI evaluation of embryos (DEVICE).

Who is sponsoring clinical trial NCT07017972?

This trial is sponsored by Fairtility, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07017972 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Fertility Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00227253 · 4,000 participants

    Chromosome 18 Clinical Research Center

  • NCT00811148 · 4,000 participants

    Florida Center for Brain Tumor Research

  • NCT00897117 · 4,000 participants

    Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer

  • NCT00899301 · 4,000 participants

    Collecting and Storing Tissue Samples From Women With or Without Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07017972, the US trial registry maintained by the National Library of Medicine. NCT07017972 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.